Alignment Healthcare Inc. (ALHC)
Alignment Healthcare Statistics
Share Statistics
Alignment Healthcare has 191.83M shares outstanding. The number of shares has increased by 1.44% in one year.
Shares Outstanding | 191.83M |
Shares Change (YoY) | 1.44% |
Shares Change (QoQ) | 0.21% |
Owned by Institutions (%) | 92.08% |
Shares Floating | 109.86M |
Failed to Deliver (FTD) Shares | 485 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 9.28M, so 4.84% of the outstanding shares have been sold short.
Short Interest | 9.28M |
Short % of Shares Out | 4.84% |
Short % of Float | 10.05% |
Short Ratio (days to cover) | 5.66 |
Valuation Ratios
The PE ratio is -16.76 and the forward PE ratio is -165.43. Alignment Healthcare's PEG ratio is 1.1.
PE Ratio | -16.76 |
Forward PE | -165.43 |
PS Ratio | 0.79 |
Forward PS | 0.4 |
PB Ratio | 21.5 |
P/FCF Ratio | -322.87 |
PEG Ratio | 1.1 |
Enterprise Valuation
Alignment Healthcare Inc. has an Enterprise Value (EV) of 1.57B.
EV / Earnings | -12.27 |
EV / Sales | 0.58 |
EV / EBITDA | -20.29 |
EV / EBIT | -15.47 |
EV / FCF | -236.34 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.08.
Current Ratio | 1.88 |
Quick Ratio | 1.88 |
Debt / Equity | 0.08 |
Total Debt / Capitalization | 7.28 |
Cash Flow / Debt | 4.44 |
Interest Coverage | -4.31 |
Financial Efficiency
Return on equity (ROE) is -1.28% and return on capital (ROIC) is -93.36%.
Return on Equity (ROE) | -1.28% |
Return on Assets (ROA) | -0.16% |
Return on Capital (ROIC) | -93.36% |
Revenue Per Employee | $1,610,220.96 |
Profits Per Employee | $-76,256.7 |
Employee Count | 1,679 |
Asset Turnover | 3.46 |
Inventory Turnover | n/a |
Taxes
Income Tax | 21K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 265.12% in the last 52 weeks. The beta is 1.5, so Alignment Healthcare's price volatility has been higher than the market average.
Beta | 1.5 |
52-Week Price Change | 265.12% |
50-Day Moving Average | 15.21 |
200-Day Moving Average | 11.6 |
Relative Strength Index (RSI) | 74.73 |
Average Volume (20 Days) | 2.17M |
Income Statement
In the last 12 months, Alignment Healthcare had revenue of 2.7B and earned -128.03M in profits. Earnings per share was -0.67.
Revenue | 2.7B |
Gross Profit | 296.69M |
Operating Income | -101.56M |
Net Income | -128.03M |
EBITDA | -77.44M |
EBIT | -101.56M |
Earnings Per Share (EPS) | -0.67 |
Balance Sheet
The company has 432.86M in cash and 7.83M in debt, giving a net cash position of 425.02M.
Cash & Cash Equivalents | 432.86M |
Total Debt | 7.83M |
Net Cash | 425.02M |
Retained Earnings | -1.01B |
Total Assets | 782.06M |
Working Capital | 309.79M |
Cash Flow
In the last 12 months, operating cash flow was 34.77M and capital expenditures -41.42M, giving a free cash flow of -6.65M.
Operating Cash Flow | 34.77M |
Capital Expenditures | -41.42M |
Free Cash Flow | -6.65M |
FCF Per Share | -0.03 |
Margins
Gross margin is 10.97%, with operating and profit margins of -3.76% and -4.74%.
Gross Margin | 10.97% |
Operating Margin | -3.76% |
Pretax Margin | -4.74% |
Profit Margin | -4.74% |
EBITDA Margin | -2.86% |
EBIT Margin | -3.76% |
FCF Margin | -0.25% |
Dividends & Yields
ALHC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -3.7% |
FCF Yield | -0.19% |
Analyst Forecast
The average price target for ALHC is $17, which is -6.1% lower than the current price. The consensus rating is "Buy".
Price Target | $17 |
Price Target Difference | -6.1% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Scores
Altman Z-Score | 4.66 |
Piotroski F-Score | 6 |